Interpace Biosciences, Inc. (IDXG) stock
IDXGOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 10/30
$5.00−0.15 (-2.91%)
Close on Oct 19, 2026Market cap $138.57MP/E 5.6Yield –
Interpace Biosciences enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Interpace Biosciences's enterprise value was $135.82M on Oct 19, 2026, against $4.01M a year earlier. Over the last 2 years it ranged from $1.75M to $207.01M, with a median of $5.85M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $135.82M | +3274.3% |
| 2025 | Dec 31, 2025 | $4.02M | -61.6% |
| 2024 | Dec 31, 2024 | $10.48M | – |
See a number that looks wrong?